Clinical trial
Islet Transplantation in Type 1 Diabetic Patients
NCT00214253 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00214253 |
|---|---|
| Title | Islet Transplantation in Type 1 Diabetic Patients |
| Official title | Islet Transplantation in Type 1 Diabetic Patients Using a Steroid-free Immunosuppression Protocol and Thiazolidinedione Insulin Sensitizers |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes |
| Intervention type | Drug |
| Interventions | Thiazolidinedione |
| Enrollment | 14 |
| Start date | Feb 1, 2002 |
| Primary completion | Oct 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | Sep 21, 2005 |
| Last update posted | Mar 31, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: